208 related articles for article (PubMed ID: 36069176)
1. Manifestations of cutaneous mycobacterial infections in patients with inborn errors of IL-12/IL-23-IFNγ immunity.
Dolezalova K; Strachan T; Matej R; Ricna D; Bloomfield M
Eur J Dermatol; 2022 Sep; 32(4):495-504. PubMed ID: 36069176
[TBL] [Abstract][Full Text] [Related]
2. Mendelian Susceptibility to Mycobacterial Disease (MSMD): Clinical and Genetic Features of 32 Iranian Patients.
Mahdaviani SA; Mansouri D; Jamee M; Zaki-Dizaji M; Aghdam KR; Mortaz E; Khorasanizadeh M; Eskian M; Movahedi M; Ghaffaripour H; Baghaie N; Hassanzad M; Chavoshzadeh Z; Mansouri M; Mesdaghi M; Ghaini M; Noori F; Eskandarzadeh S; Kahkooi S; Poorabdolah M; Tabarsi P; Moniri A; Farnia P; Karimi A; Boisson-Dupuis S; Rezaei N; Marjani M; Casanova JL; Bustamante J; Velayati AA
J Clin Immunol; 2020 Aug; 40(6):872-882. PubMed ID: 32602053
[TBL] [Abstract][Full Text] [Related]
3. Impaired IL-12- and IL-23-Mediated Immunity Due to IL-12Rβ1 Deficiency in Iranian Patients with Mendelian Susceptibility to Mycobacterial Disease.
Nekooie-Marnany N; Deswarte C; Ostadi V; Bagherpour B; Taleby E; Ganjalikhani-Hakemi M; Le Voyer T; Rahimi H; Rosain J; Pourmoghadas Z; Sheikhbahaei S; Khoshnevisan R; Petersheim D; Kotlarz D; Klein C; Boisson-Dupuis S; Casanova JL; Bustamante J; Sherkat R
J Clin Immunol; 2018 Oct; 38(7):787-793. PubMed ID: 30255293
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of interleukin-12 receptor β1 and interferon gamma receptor 1 deficiency in patients with disseminated BCG infection.
Pourakbari B; Hosseinpour Sadeghi R; Mahmoudi S; Parvaneh N; Keshavarz Valian S; Mamishi S
Allergol Immunopathol (Madr); 2019; 47(1):38-42. PubMed ID: 30268380
[TBL] [Abstract][Full Text] [Related]
5. Clinical and Molecular Findings in Mendelian Susceptibility to Mycobacterial Diseases: Experience From India.
Taur PD; Gowri V; Pandrowala AA; Iyengar VV; Chougule A; Golwala Z; Chandak S; Agarwal R; Keni P; Dighe N; Bodhanwala M; Prabhu S; George B; Fouzia NA; Edison ES; Arunachalam AK; Madkaikar MR; Dalvi AD; Yadav RM; Bargir UA; Kambli PM; Rawat A; Das J; Joshi V; Pilania RK; Jindal AK; Bhat S; Bhattad S; Unni J; Radhakrishnan N; Raj R; Uppuluri R; Patel S; Lashkari HP; Aggarwal A; Kalra M; Udwadia Z; Bafna VS; Kanade T; Puel A; Bustamante J; Casanova JL; Desai MM
Front Immunol; 2021; 12():631298. PubMed ID: 33732252
[TBL] [Abstract][Full Text] [Related]
6. Molecular, Immunological, and Clinical Features of 16 Iranian Patients with Mendelian Susceptibility to Mycobacterial Disease.
Sarrafzadeh SA; Nourizadeh M; Mahloojirad M; Fazlollahi MR; Shokouhi Shoormasti R; Badalzadeh M; Deswarte C; Casanova JL; Pourpak Z; Bustamante J; Moin M
J Clin Immunol; 2019 Apr; 39(3):287-297. PubMed ID: 30715640
[TBL] [Abstract][Full Text] [Related]
7. Mendelian Susceptibility to Mycobacterial Disease: Retrospective Clinical and Genetic Study in Mexico.
Peñafiel Vicuña AK; Yamazaki Nakashimada M; León Lara X; Mendieta Flores E; Nuñez Núñez ME; Lona-Reyes JC; Hernández Nieto L; Ramírez Vázquez MG; Barroso Santos J; López Iñiguez Á; González Y; Torres M; Lezana Fernández JL; Román Montes CM; Medina-Torres EA; González Serrano E; Bustamante Ogando JC; Lugo Reyes S; Zavaleta Martínez O; Staines Boone AT; Venegas Montoya E; Aguilar Gómez NE; Soudeé C; Jouanguy E; Puel A; Boisson-Dupuis S; Pedraza Sánchez S; Casanova JL; Espinosa Rosales F; Espinosa Padilla S; Bustamante J; Blancas Galicia L
J Clin Immunol; 2023 Jan; 43(1):123-135. PubMed ID: 36044171
[TBL] [Abstract][Full Text] [Related]
8. Mendelian susceptibility to mycobacterial disease in tuberculosis-hyperendemic South Africa.
Cornelissen HM; Glanzmann B; Van Coller A; Engelbrecht C; Abraham DR; Reddy K; Möller M; Kinnear C; Glashoff RH; Esser M
S Afr Med J; 2021 Oct; 111(10):998-1005. PubMed ID: 34949297
[TBL] [Abstract][Full Text] [Related]
9. Novel STAT1 Variants in Japanese Patients with Isolated Mendelian Susceptibility to Mycobacterial Diseases.
Ono R; Tsumura M; Shima S; Matsuda Y; Gotoh K; Miyata Y; Yoto Y; Tomomasa D; Utsumi T; Ohnishi H; Kato Z; Ishiwada N; Ishikawa A; Wada T; Uhara H; Nishikomori R; Hasegawa D; Okada S; Kanegane H
J Clin Immunol; 2023 Feb; 43(2):466-478. PubMed ID: 36336768
[TBL] [Abstract][Full Text] [Related]
10. Eight years of follow-up experience in children with mendelian susceptibility to mycobacterial disease and review of the literature.
Azarsiz E; Karaca N; Karaca E; Aksu G; Genel F; Gulez N; Ozen S; Kutukculer N
Asian Pac J Allergy Immunol; 2023 Dec; 41(4):372-378. PubMed ID: 33638623
[TBL] [Abstract][Full Text] [Related]
11. Immune defects in active mycobacterial diseases in patients with primary immunodeficiency diseases (PIDs).
Lee WI; Huang JL; Yeh KW; Jaing TH; Lin TY; Huang YC; Chiu CH
J Formos Med Assoc; 2011 Dec; 110(12):750-8. PubMed ID: 22248828
[TBL] [Abstract][Full Text] [Related]
12. Laboratory evaluation of the IFN-γ circuit for the molecular diagnosis of Mendelian susceptibility to mycobacterial disease.
Esteve-Solé A; Sologuren I; Martínez-Saavedra MT; Deyà-Martínez À; Oleaga-Quintas C; Martinez-Barricarte R; Martin-Nalda A; Juan M; Casanova JL; Rodriguez-Gallego C; Alsina L; Bustamante J
Crit Rev Clin Lab Sci; 2018 May; 55(3):184-204. PubMed ID: 29502462
[TBL] [Abstract][Full Text] [Related]
13. A Syrian Refugee in Iraq Diagnosed as a Case of IL12RB1 Deficiency in Japan Using Dried Blood Spots.
Al-Kzayer LFY; Yassin AK; Salih KH; Shigemura T; Sano K; Al-Simaani RBY; Tanaka M; Nakazawa Y; Okuno Y
Front Immunol; 2019; 10():58. PubMed ID: 30740107
[TBL] [Abstract][Full Text] [Related]
14. Genetic, immunologic, and clinical features of 830 patients with Mendelian susceptibility to mycobacterial diseases (MSMD): A systematic review.
Khavandegar A; Mahdaviani SA; Zaki-Dizaji M; Khalili-Moghaddam F; Ansari S; Alijani S; Taherzadeh-Ghahfarrokhi N; Mansouri D; Casanova JL; Bustamante J; Jamee M
J Allergy Clin Immunol; 2024 May; 153(5):1432-1444. PubMed ID: 38341181
[TBL] [Abstract][Full Text] [Related]
15. Impaired interferon gamma-mediated immunity and susceptibility to mycobacterial infection in childhood.
Remus N; Reichenbach J; Picard C; Rietschel C; Wood P; Lammas D; Kumararatne DS; Casanova JL
Pediatr Res; 2001 Jul; 50(1):8-13. PubMed ID: 11420412
[TBL] [Abstract][Full Text] [Related]
16. Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-γ immunity.
Bustamante J; Boisson-Dupuis S; Abel L; Casanova JL
Semin Immunol; 2014 Dec; 26(6):454-70. PubMed ID: 25453225
[TBL] [Abstract][Full Text] [Related]
17. Inherited disorders of IL-12- and IFNgamma-mediated immunity: a molecular genetics update.
Döffinger R; Dupuis S; Picard C; Fieschi C; Feinberg J; Barcenas-Morales G; Casanova JL
Mol Immunol; 2002 May; 38(12-13):903-9. PubMed ID: 12009568
[TBL] [Abstract][Full Text] [Related]
18. Impaired IFNγ-Signaling and Mycobacterial Clearance in IFNγR1-Deficient Human iPSC-Derived Macrophages.
Neehus AL; Lam J; Haake K; Merkert S; Schmidt N; Mucci A; Ackermann M; Schubert M; Happle C; Kühnel MP; Blank P; Philipp F; Goethe R; Jonigk D; Martin U; Kalinke U; Baumann U; Schambach A; Roesler J; Lachmann N
Stem Cell Reports; 2018 Jan; 10(1):7-16. PubMed ID: 29249666
[TBL] [Abstract][Full Text] [Related]
19. The Child with Recurrent Mycobacterial Disease.
Reed B; Dolen WK
Curr Allergy Asthma Rep; 2018 Jun; 18(8):44. PubMed ID: 29936646
[TBL] [Abstract][Full Text] [Related]
20. Disseminated Bacillus Calmette-Guérin and Susceptibility to Mycobacterial Infections-Implications on Bacillus Calmette-Guérin Vaccinations.
Lee PP
Ann Acad Med Singap; 2015 Aug; 44(8):297-301. PubMed ID: 26477962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
